- Home
- JOB vs LITS Comparison
JOB vs LITS Comparison
Compare JOB & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | LITS |
|---|---|---|
| Founded | 1893 | 2000 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9M | 25.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JOB | LITS |
|---|---|---|
| Price | $0.21 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 140.3K | 135.2K |
| Earning Date | 05-14-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | ★ $96,504,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.69 |
| 52 Week High | $0.28 | $3.03 |
Technical Indicators
Market Signals| Indicator | JOB | LITS |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 44.55 |
| Support Level | $0.21 | $0.79 |
| Resistance Level | $0.22 | $0.99 |
| Average True Range (ATR) | 0.01 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 14.39 | 16.10 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About LITS Lite Strategy Inc.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.